Patrick Fagan

Patrick Fagan is a seasoned scientist with extensive experience in drug discovery and pharmacology, currently serving as Senior Scientist in In-Vitro Pharmacology at Radionetics Oncology since September 2024. Prior roles include Senior Scientist at Erasca, Inc., where research focused on early-stage oncology projects and structure-based drug discovery related to the RAS/MAPK pathway. Patrick also contributed to the understanding of receptor signaling in anti-tumor responses at IGNYTA, Inc. Other experience encompasses biochemistry and molecular biology roles across various prestigious organizations, including Johnson & Johnson, where support was provided for oncology T-Cell therapy, and Pfizer, focusing on small-molecule drug discovery. Patrick holds a BA in Biology from San Diego State University.